Aptorum Group Ltd. (APM)
1.07
-0.10
(-8.55%)
USD |
NASDAQ |
Jun 09, 15:19
Aptorum Group SG&A Expense (Quarterly) : 0.2117M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Bicycle Therapeutics Plc | 17.44M |
| Centessa Pharmaceuticals Plc | 19.85M |
| Roivant Sciences Ltd. | 158.25M |
| Adaptimmune Therapeutics Plc | 18.71M |
| Kiniksa Pharmaceuticals International Plc | 61.15M |